Entospletinib,Lanraplenib
Kronos Bio,gilead
[]
$kron new article : kronos bio continues to advance investigational syk inhibitors entospletinib and lanraplenib with new preclinical data at eha2022 congress get all the latest $kron related news here : 
We'll make staying up-to-date on financials news easy for you. Discover how https://t.co/qYtx6dQ3dV revolutionizes how you gather financial related news